Download PDF	PROVEN CONTROL IN 2 PIVOTAL TRIALS Learn about the largest randomized active comparator controlled trials in acromegaly.1,2   Reference: 1. Colao A, Bronstein MD, Freda P, et al. Pasireotide versus octreotide in acromegaly: a head-to-head superiority study. J Clin Endocrinol Metab. 2014;99(3):791-799. 2. Gadelha MR, Bronstein MD, Brue T, et al. Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomized, phase 3 trial. Lancet Diabetes Endocrinol. 2014;2(11):875-884. doi:10.1016/S2213-8587(14)